Manhattan Assistant District Attorney Joel Seidemann and his team filed a court motion on Friday seeking to preserve the state‑level murder case against 28‑year‑old Luigi Mangione. The prosecutors argue that Mangione’s recent federal guilty plea on stalking and cyberstalking charges should not automatically end the separate New York State prosecution for murder, weapons and fake‑ID offenses tied to the December 2024 killing of UnitedHealthcare CEO Brian Thompson.
Different harms, different crimes
In the filing, Seidemann emphasized that the state and federal cases address “different harms, different evils, different purposes, different crimes.” While both proceedings stem from the same fatal shooting, the Manhattan prosecutors contend that the legal elements and criminal conduct alleged in the state case differ enough to avoid a double‑jeopardy bar.
Under double jeopardy law, a defendant cannot be tried twice for the same offense. Mangione’s defense attorneys have moved to dismiss the state charges, asserting that the federal plea already resolves the matter. They point to prior court papers stating that the state and federal governments are “prosecuting the same man twice for the same event.”
Federal plea and state charges
In August, Mangione pleaded guilty in federal court to stalking and cyberstalking after traveling across state lines to New York, where he shot Thompson from behind on a Manhattan street. He told the court he acted after years of severe back pain and frustration with the health‑insurance system.
Separately, Mangione entered a not‑guilty plea in 2024 to state charges of murder, weapons violations and possession of a fake ID. If the state case proceeds to trial, prosecutors say his federal admission could be used as evidence.
Potential consequences
A ruling on the motion is expected in late autumn. Should the state case move forward, Mangione could face an additional prison term on top of the lengthy federal sentence he is already likely to receive.
Thompson, 50, was the chief executive of one of the nation’s largest health insurers. The ammunition used in the killing bore markings such as “delay,” “deny” and “depose,” a detail that has resonated with many Americans who are frustrated with the health‑insurance industry.
Background on the defendant
Mangione comes from a prominent Maryland real‑estate family and holds undergraduate and master’s degrees in computer science. He previously worked for a car‑buying website and, according to police, never held UnitedHealthcare insurance.
The case highlights the tension between federal and state jurisdictions when a single act gives rise to multiple criminal allegations. New York prosecutors remain confident that the state court has a distinct role to play in seeking justice for Thompson’s death.
Original reporting: Alexandria, VA News – WTOP News — read the source article.
